Thursday November 26 2009 | Biotechnology feed | All feeds
|
|
Berna Biotech AG
Download detailed PDF Members: Founded in 1898 as the Swiss Serum and Vaccine Institute Berne, Berna Biotech Ltd (Swiss Exchange: BBIN) develops, produces and markets vaccines for private and public markets world-wide. Headquartered in Berne, Switzerland, with subsidiaries in Europe, and Korea, Berna is a well-established fully integrated vaccines company, employing around 700 people. Berna has state-of-the-art R&D facilities in Switzerland, Germany and Korea; manufacturing facilities in Switzerland, Spain and Korea; and a sales and marketing infrastructure in its core markets Switzerland, Italy, Spain and Korea. Berna's range of novel and validated proprietary technology platforms supports a strong product portfolio. The company markets its core vaccine products in the field of paediatric, respiratory and travel vaccines and has a focused research and development pipeline.
This page has been viewed 484 times since April 2007, the link to the organisation's website has been followed 88 times Recent Search Terms used to find this page: berna biotech korea | berna biotech pipeline | . Search for more companies in Bern This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Berna Biotech AG | ||||||||||||||||||||||||||||||||||||||||||
|